Transaction in Own Shares

Summary by AI BETAClose X

Fevertree Drinks plc has announced the purchase of 177,447 ordinary shares between July 27th and July 31st, 2026, as part of its share buyback program. The volume-weighted average price for these purchases ranged from 823.79p to 866.44p, with the lowest price per share at 814.00p and the highest at 875.50p. The company intends to cancel these repurchased shares.

Disclaimer*

Fevertree Drinks PLC
04 August 2026
 

4th August 2026                     

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 27th July to 31st July 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

27 July 2026

XLON

823.7899

19,437

814.0000

830.5000

27 July 2026

AIMX

829.5000

25,000

829.5000

829.5000

28 July 2026

XLON

835.8301

20,364

822.0000

848.0000

28 July 2026

AIMX

829.0000

25,000

829.0000

829.0000

29 July 2026

XLON

849.6202

15,083

843.0000

854.0000

29 July 2026

AIMX

847.0000

20,000

847.0000

847.0000

30 July 2026

XLON

863.6094

34,021

854.5000

875.5000

30 July 2026

AIMX

860.0000

19,733

860.0000

860.0000

31 July 2026

XLON

866.4371

17,867

859.0000

874.5000

31 July 2026

AIMX

869.0000

20,000

868.0000

870.0000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/9734O_1-2026-8-3.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings